US · Healthcare

Amplia Therapeutics Limited (INNMF)

Biotechnology

Amplia Therapeutics Limited (INNMF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for INNMF

P/E ratio

18.00

Amplia Therapeutics Limited (INNMF) — FAQ

What is INNMF's P/E ratio?

The price-to-earnings (P/E) ratio for Amplia Therapeutics Limited (INNMF) is 18.00 (data as of 2026-03-24).

Does Amplia Therapeutics Limited pay a dividend?

Dividend yield is not available in the current snapshot for Amplia Therapeutics Limited (INNMF). Check the MyAverix Finance app for the latest dividend data.

What sector is Amplia Therapeutics Limited in?

Amplia Therapeutics Limited (INNMF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is INNMF listed on?

INNMF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)